Dr. Moise Khayrallah
Entrepreneur-in-Residence, Blackstone Entrepreneurs Network
Dr. Khayrallah is an NC Blackstone Entrepreneurs Network Entrepreneur-in-Residence. He has been involved in drug development for 28 years in executive as well as research and development positions. He acquired his experience in diverse pharmaceutical environments including large pharmaceutical, contract research, and biotechnology companies. He is presently CEO and co-Founder of Aerial BioPharma, LLC, a biopharmaceutical holding company focused on developing drugs for treating several central nervous system disorders.
In 2010, Dr. Khayrallah was co-founder, President and CEO of Neuronex Inc, a company focused on developing treatments for patients with certain seizure disorders. Neuronex was acquired by Acorda Therapeutics in late 2012. In 2006, he co-founded and served as President and CEO of Addrenex Pharmaceuticals, Inc., a specialty pharmaceuticals company that developed and received FDA approvals for compounds targeting the adrenergic system. Addrenex was acquired in late 2009 by Shionogi & Co. of Japan. In 2002, Dr. Khayrallah founded a consulting company, Alius Pharma, LLC, to partner with small biotechnology companies in cancer drug development. From 1999 to 2002, he was VP of Clinical Affairs at Cytran, Inc., a Seattle area biotechnology company, where he led the product development team for the company’s lead compound in cancer and participated in financing and joint venture activities. Prior to that, Dr. Khayrallah served as Director, Clinical Research and Regulatory Affairs at Lineberry Research Associates (later Constella Group and SRI International) in RTP, NC. While at Lineberry, he led project teams in implementing clinical projects and providing strategic consulting in several therapeutic areas. Dr. Khayrallah also served in various positions at Burroughs Wellcome and later Glaxo Wellcome from 1987 to 1996, where he led clinical programs and trials resulting in FDA approvals in CNS indications. He holds a Ph.D. degree in psychology from the University of North Carolina at Chapel Hill.